Do you want to read an article? Please log in or register.
Urinary tartaric acid as a biomarker of wine consumption and cardiovascular risk: the PREDIMED trial
Cardiovascular Risk and Diseases
Related content
Cardiovascular Risk and Diseases
Bempedoic Acid Reduces the Risk of Major Adverse Cardiovascular Events Across Patient Subgroups
Cardiovascular Risk and Diseases
Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors
Cardiovasc Diabetol
Zhang XR, Zhong WF, Liu RY, Huang JL, Fu JX, Gao J, Zhang PD, Liu D, Li ZH, He Y, Zhou H, Li Z
doi: 10.1186/s12933-025-02711-x
Cardiovascular Risk and Diseases
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study
J Thromb Haemost
Kraler S, Liberale L, Nopp S, Englisch C, Grilz E, Lapikova-Bryhinska T, Akhmedov A, Carbone F, Ramoni D, Tirandi A, Scuricini A, Isoppo S, Tortorella C, La Rosa F, Michelauz C, Frè F, Gavoci A, Lisa A, Suter TM, von Eckardstein A, Wenzl FA, Pabinger I, Lüscher TF, Montecucco F, Ay C, Moik F
doi: 10.1016/j.jtha.2024.07.019
Heart, Artery and Coronary Diseases
Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial
Eur Heart J
Nurmohamed NS, Min JK, Anthopolos R, Reynolds HR, Earls JP, Crabtree T, Mancini GBJ, Leipsic J, Budoff MJ, Hague CJ, O'Brien SM, Stone GW, Berger JS, Donnino R, Sidhu MS, Newman JD, Boden WE, Chaitman BR, Stone PH, Bangalore S, Spertus JA, Mark DB, Shaw LJ, Hochman JS, Maron DJ
doi: 10.1093/eurheartj/ehae471
RECOMMENDED
Cardiovascular Risk and DiseasesFurther Publications
Efficacy and Safety of Lerodalcibep in Patients With or at High Risk of Cardiovascular Disease: A Randomized Clinical Trial
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
JAMA Cardiol
Klug EQ, Llerena S, Burgess LJ, Fourie N, Scott R, Vest J, Caldwell K, Kallend D, Stein EA, LIBERATE-HR Investigators
doi: 10.1001/jamacardio.2024.1659
RECOMMENDED
Heart, Artery and Coronary Diseases
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Atherosclerosis
Burger PM, Dorresteijn JAN, Koudstaal S, Holtrop J, Kastelein JJP, Jukema JW, Ridker PM, Mosterd A, Visseren FLJ
doi: 10.1016/j.atherosclerosis.2024.118540
COMMENTED
Cardiovascular Risk and Diseases
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Hauge JW, Borgeraas H, Birkeland KI, Johnson LK, Hertel JK, Hagen M, Gulseth HL, Lindberg M, Lorentzen J, Seip B, Kolotkin RL, Svanevik M, Valderhaug TG, Sandbu R, Hjelmesæth J, Hofsø D
doi: 10.1016/S2213-8587(24)00396-6
Cardiovascular Risk and Diseases
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors: The SAHELI Randomized Clinical Trial
JAMA Cardiol
Kandula NR, Shah NS, Kumar S, Charley M, Clauson M, Lancki N, Finch EA, Ehrlich-Jones L, Rao G, Spring B, Shah NS, Siddique J
doi: 10.1001/jamacardio.2024.2526
RECOMMENDED
Cardiovascular Risk and Diseases
Long-Term Changes to Cardiovascular Biomarkers After Hormone Therapy in the Women's Health Initiative Hormone Therapy Clinical Trials
★ 2
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Obstet Gynecol
Nudy M, Aragaki AK, Jiang X, Manson JE, Shadyab AH, Jung SY, Martin LW, Wild RA, Womack C, Mouton CP, Rossouw JE, Schnatz PF
doi: 10.1097/AOG.0000000000005862